Clinical trial
Decitabine and Valproic Acid in Treating Patients With Refractory or Relapsed…
NCT00079378 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00079378 |
|---|---|
| Title | Decitabine and Valproic Acid in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma |
| Official title | A Phase I Study of Decitabine in Combination With Valproic Acid in Patients With Selected Hematologic Malignancies |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13, q22), Adult Acute Myeloid Leukemia With t(15, 17)(q22, q12), Adult Acute Myeloid Leukemia With t(16, 16)(p13, Adult Acute Myeloid Leukemia With t(8 and 5 more |
| Intervention type | Drug, Other |
| Interventions | decitabine, valproic acid, pharmacological study, laboratory biomarker analysis |
| Enrollment | 84 |
| Start date | Feb 1, 2004 |
| Primary completion | May 1, 2011 |
| First posted | Mar 10, 2004 |
| Last update posted | Sep 30, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: